Dr. Tarun Chakravarty, MD

Dr. Chakravarty practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Chakravarty's NPI, 1194097303, was assigned on February 2, 2012. Dr. Chakravarty graduated from Maulana Azad Medical College in 2007. Dr. Chakravarty holds California license A119709.

Dr. Chakravarty's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Chakravarty's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Chakravarty to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chakravarty practices. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Chakravarty's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Chakravarty is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Chakravarty is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and pacemaker or defibrillator implantation among the conditions Dr. Chakravarty treats.

CMS data shows 1,259 Medicare services from Dr. Chakravarty across 17 procedure codes in 2024, for 667 Medicare patients. Medicare paid $341,874 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 667 Medicare patients who saw Dr. Chakravarty in 2024. The largest group is 75 to 84, with 269 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chakravarty's median patient age at 76, with 37% women.

In 2024, Dr. Chakravarty wrote 245 Medicare Part D claims for 89 patients. 57% of them were for generic drugs. CMS names the drug for 146 of them, across 6 drugs with 11 or more claims each, at $55,532 in total drug cost. In 2023, CMS named 78 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Chakravarty for performance year 2024, reported as part of a group. Dr. Chakravarty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chakravarty as offering telehealth. CMS counts 141 procedures of coronary angioplasty and stenting by Dr. Chakravarty, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 118 papers to Dr. Chakravarty, published from 2011 to 2025. 2020 was the busiest year, with 16. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis and Heart Valve Prosthesis. Dr. Chakravarty has published most often in JACC Cardiovasc Interv. Dr. Chakravarty's most frequent co-authors are Raj R. Makkar, MD, Mamoo Nakamura, MD and Stamatios Lerakis, MD.

Dmand AI links Dr. Chakravarty to 3 clinical trials. 2 are still active or recruiting. Conditions studied include COVID-19, Tricuspid Valve Insufficiency and Gastroesophageal Reflux.

CMS Open Payments shows 1,657 general payments to Dr. Chakravarty from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Edwards Lifesciences Corporation paid the most, $51,750.

Dr. Chakravarty graduated from Maulana Azad Medical College in 2007. Dr. Chakravarty is a member of ACC.

Dr. Chakravarty is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.